A Study of RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities

Completed · Phase 2 · Has a placebo group

Conditions studied: Obesity

In brief

The main purpose of this study was to evaluate the safety and tolerability of RGT001-075 in healthy participants with obesity

Key facts

Study ID
NCT06277934
Run by
Regor Pharmaceuticals Inc.
People needed
73
Starts
2024-03-08
Expected to finish
2024-08-13
Last updated by the study team
2025-08-07

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.